732 related articles for article (PubMed ID: 19394376)
21. Transcriptional targeting for ovarian cancer gene therapy.
Casado E; Nettelbeck DM; Gomez-Navarro J; Hemminki A; Gonzalez Baron M; Siegal GP; Barnes MN; Alvarez RD; Curiel DT
Gynecol Oncol; 2001 Aug; 82(2):229-37. PubMed ID: 11531272
[TBL] [Abstract][Full Text] [Related]
22. Oncolytic virotherapy for cancer treatment: challenges and solutions.
Davis JJ; Fang B
J Gene Med; 2005 Nov; 7(11):1380-9. PubMed ID: 16025557
[TBL] [Abstract][Full Text] [Related]
23. Gene-viral cancer therapy using dual-regulated oncolytic adenovirus with antiangiogenesis gene for increased efficacy.
Su C; Na M; Chen J; Wang X; Liu Y; Wang W; Zhang Q; Li L; Long J; Liu X; Wu M; Fan X; Qian Q
Mol Cancer Res; 2008 Apr; 6(4):568-75. PubMed ID: 18344493
[TBL] [Abstract][Full Text] [Related]
24. Gene therapy of brain and endocrine tumors.
Palù G; Bonaguro R; Gnatta E; Franchin E; Barzon L
Croat Med J; 2001 Aug; 42(4):473-7. PubMed ID: 11471203
[TBL] [Abstract][Full Text] [Related]
25. Targeted gene-delivery strategies for angiostatic cancer treatment.
Brandwijk RJ; Griffioen AW; Thijssen VL
Trends Mol Med; 2007 May; 13(5):200-9. PubMed ID: 17379575
[TBL] [Abstract][Full Text] [Related]
26. Noninfectious gene transfer and expression systems for cancer gene therapy.
Cooper MJ
Semin Oncol; 1996 Feb; 23(1):172-87. PubMed ID: 8607027
[TBL] [Abstract][Full Text] [Related]
27. Development of transcriptionally regulated oncolytic adenoviruses.
Ko D; Hawkins L; Yu DC
Oncogene; 2005 Nov; 24(52):7763-74. PubMed ID: 16299536
[TBL] [Abstract][Full Text] [Related]
28. Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers.
Zeh HJ; Bartlett DL
Cancer Gene Ther; 2002 Dec; 9(12):1001-12. PubMed ID: 12522439
[TBL] [Abstract][Full Text] [Related]
29. Replicative adenoviruses for cancer therapy.
Alemany R; Balagué C; Curiel DT
Nat Biotechnol; 2000 Jul; 18(7):723-7. PubMed ID: 10888838
[TBL] [Abstract][Full Text] [Related]
30. Potential of tumour cells for delivering oncolytic viruses.
Raykov Z; Rommelaere J
Gene Ther; 2008 May; 15(10):704-10. PubMed ID: 18356816
[TBL] [Abstract][Full Text] [Related]
31. Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors.
Foka P; Pourchet A; Hernandez-Alcoceba R; Doumba PP; Pissas G; Kouvatsis V; Dalagiorgou G; Kazazi D; Marconi P; Foschini M; Manservigi R; Konstadoulakis MM; Koskinas J; Epstein AL; Mavromara P
J Gene Med; 2010 Dec; 12(12):956-67. PubMed ID: 21104973
[TBL] [Abstract][Full Text] [Related]
32. Design of virotherapy for effective tumor treatment.
Garcia-Aragoncillo E; Hernandez-Alcoceba R
Curr Opin Mol Ther; 2010 Aug; 12(4):403-11. PubMed ID: 20677091
[TBL] [Abstract][Full Text] [Related]
33. Tissue-specific promoters active in CD44+CD24-/low breast cancer cells.
Bauerschmitz GJ; Ranki T; Kangasniemi L; Ribacka C; Eriksson M; Porten M; Herrmann I; Ristimäki A; Virkkunen P; Tarkkanen M; Hakkarainen T; Kanerva A; Rein D; Pesonen S; Hemminki A
Cancer Res; 2008 Jul; 68(14):5533-9. PubMed ID: 18632604
[TBL] [Abstract][Full Text] [Related]
34. Gene-modified bone marrow cell therapy for prostate cancer.
Wang H; Thompson TC
Gene Ther; 2008 May; 15(10):787-96. PubMed ID: 18385769
[TBL] [Abstract][Full Text] [Related]
35. Insulated hsp70B' promoter: stringent heat-inducible activity in replication-deficient, but not replication-competent adenoviruses.
Rohmer S; Mainka A; Knippertz I; Hesse A; Nettelbeck DM
J Gene Med; 2008 Apr; 10(4):340-54. PubMed ID: 18265421
[TBL] [Abstract][Full Text] [Related]
36. The emergence of combinatorial strategies in the development of RNA oncolytic virus therapies.
Nguyen TL; Tumilasci VF; Singhroy D; Arguello M; Hiscott J
Cell Microbiol; 2009 Jun; 11(6):889-97. PubMed ID: 19388908
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy.
Izumo T; Ohtsuru A; Tokunaga Y; Namba H; Kaneda Y; Nagata I; Yamashita S
Int J Oncol; 2007 Aug; 31(2):379-87. PubMed ID: 17611695
[TBL] [Abstract][Full Text] [Related]
38. Cancer-selective induction of cytotoxicity by tissue-specific expression of targeted trans-splicing ribozyme.
Song MS; Lee SW
FEBS Lett; 2006 Sep; 580(21):5033-43. PubMed ID: 16949075
[TBL] [Abstract][Full Text] [Related]
39. Endothelial progenitor cells as cellular vehicles to deliver oncolytic virus therapies to metastatic tumors: the "Trojan horse" approach.
Deng W; Jia J
Med Hypotheses; 2008; 70(4):842-4. PubMed ID: 17869010
[TBL] [Abstract][Full Text] [Related]
40. Reporter gene imaging: potential impact on therapy.
Serganova I; Blasberg R
Nucl Med Biol; 2005 Oct; 32(7):763-80. PubMed ID: 16243653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
